Skip to content
  • About
  • Contact
  • Contribute
  • What Physicians Say
  • My Book
  • Careers
  • Podcast
  • Speaking
KevinMD.com — Social media's leading physician voice
  • All
  • Physician
  • Burnout
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • All
  • Physician
  • Burnout
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
    • All
    • Physician
    • Burnout
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • About
    • Contact
    • Contribute
    • What Physicians Say
    • My Book
    • Careers
    • Podcast
    • Speaking
KevinMD.com — Social media's leading physician voice
  • All
  • Physician
  • Burnout
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
    • All
    • Physician
    • Burnout
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • About
    • Contact
    • Contribute
    • What Physicians Say
    • My Book
    • Careers
    • Podcast
    • Speaking
  • About Kevin Pho, MD, Founder of KevinMD
  • Aging and dementia: what physicians say, in their own words
  • Artificial intelligence: what physicians say, in their own words
  • Be heard on social media’s leading physician voice
  • Cancer: what physicians say, in their own words
  • Children’s health: what pediatricians say, in their own words
  • Contact Kevin
  • COVID-19: what physicians wrote as it happened
  • Custom enhanced author page pricing
  • Diabetes and obesity: what physicians say, in their own words
  • Direct primary care: what physicians say, in their own words
  • DMCA Policy
  • End of life: what physicians say, in their own words
  • Establishing, Managing, and Protecting Your Online Reputation: A Social Media Guide for Physicians and Medical Practices
  • GLP-1 drugs: what physicians say about Ozempic and its successors, in their own words
  • Heart disease: what physicians say, in their own words
  • Immigration and medicine: what physicians say about immigrant doctors and immigrant patients, in their own words
  • KevinMD influencer opportunities
  • Medical errors: what physicians say, in their own words
  • Medical ethics: what physicians say, in their own words
  • Medical malpractice: what physicians say, in their own words
  • Medical school: what students and physicians say, in their own words
  • Mental health: what psychiatrists and physicians say, in their own words
  • Nursing: what nurses and physicians say, in their own words
  • Opinion and commentary by KevinMD
  • Opioids: what physicians and pain patients say, in their own words
  • Physician burnout speakers to keynote your conference
  • Physician burnout: what physicians say, in their own words
  • Physician Coaching by KevinMD
  • Physician keynote speaker: Kevin Pho, MD
  • Physician personal finance: what physicians say about their own money, in their own words
  • Physician Speaking by KevinMD: a boutique speakers bureau
  • Physician suicide: what physicians say, in their own words
  • Physicians and administrators: what physicians say about who runs medicine, in their own words
  • Primary care physician in Nashua, NH | Kevin Pho, MD
  • Primary care: what physicians say, in their own words
  • Prior authorization: what physicians say, in their own words
  • Privacy Policy
  • Private equity and corporate medicine: what physicians say, in their own words
  • Race and medicine: what physicians say, in their own words
  • Recommended services by KevinMD
  • Residency: what residents and attendings say, in their own words
  • Scope of practice: what physicians, nurse practitioners, and PAs say, in their own words
  • Subscribe to the KevinMD enhanced author page
  • Subscribe to the newsletter
  • Surgeons and surgery: what surgeons say, in their own words
  • Take-home messages: what physicians say when asked to leave one
  • Terms of Use Agreement
  • Thank you for subscribing to KevinMD
  • Thank you for upgrading to the KevinMD enhanced author page
  • The electronic health record: what physicians say, in their own words
  • Vaccines: what physicians say, in their own words
  • Violence against health care workers: what physicians and nurses say, in their own words
  • What physicians say: the KevinMD records
  • Women in medicine: what women physicians say, in their own words
  • Women’s health: what physicians say, in their own words

A cancer patient who had bad luck with clinical trials

Nathan A. Pennell, MD, PhD
Conditions and Diseases
October 30, 2015
Share
Tweet
Share

asco-logo I am superstitious, and I freely admit it. I don’t use the word “cure” with patients until the 5-year scan has come and gone cleanly. I don’t celebrate the scans showing tumor response until I see them myself and make sure I am not mixing up the new scan with the old. And one of my most closely held superstitions is that the nicest patients seem to have the worst luck. We used to note morbidly in fellowship that sweet dispositions were a poor prognostic sign, as if our patients’ bad outcomes were punishments to us for coming to care about them. Nonsense of course, and yet absolutely true. Wait, what’s recall bias?

I was reading the recent post by ASCO President Julie Vose titled “Why is getting a patient on a clinical trial so difficult?” Dr. Vose’s post made me think of a patient of mine who seemed to have the just opposite problem: She could get onto any trial I suggested, but couldn’t seem to buy a break.

Mrs. K is a wonderful 65-year-old woman who just makes you smile when you see her. She is sunny and optimistic, with a quiet and supportive spouse who complements her well. She came to me in 2013 with metastatic non-small cell lung cancer, and together we decided to enroll her on a clinical trial we had open at the time. She agreed in the spirit that it might help someone else even if she didn’t get any benefit. She was randomly assigned to chemotherapy plus drug or placebo; we never knew which, and initially it worked but before long her cancer was advancing again. That trial was eventually reported to be completely negative for any benefit from the experimental drug.

We had a second-line trial open as well, and again we discussed the options and she decided to enroll. This one was randomized but not blinded, and she was assigned to chemotherapy alone. She took this disappointment in stride, but, unfortunately, her cancer took it in stride as well and progressed despite the chemotherapy.

Still, she felt good and wanted to do something more, so I offered her a third clinical trial. This one was a harder sell, because it required a new biopsy, and she could only go on the trial if a potential biomarker was positive on the biopsy. We discussed the pros and cons, and I informed her that the results with this drug had been quite good in the biomarker-positive tumors, and anyway the odds were about 50-50 so maybe she would get lucky this time. She smiled, agreed, and you can guess the rest. The biopsy was negative, and she was not eligible for the trial.

It was hard to escape the feeling that luck simply wasn’t with her, but we had just gotten an open slot on a trial of a similar drug that did not require a biomarker test. She was having chest pain at that point and losing some weight, but it hadn’t dulled her smile in the least. “Whatever you suggest, Doctor. I trust you.” I could feel an almost palpable sense of doom.

We started her on the trial, and her first set of restaging scans looked worse, which I had come to expect by this time. However, when I saw her to discuss them, her symptoms had actually started to improve. Her pain was almost gone, which didn’t make much sense, but this new drug belongs to a class of drugs that can have delayed responses, so we decided to continue it anyway. I also didn’t have a better suggestion to try.

When I saw her next, she looked fantastic, with no pain and back to her baseline weight. I remember she even complimented me on my Van Gogh tie. When I opened her scans, I double-checked to make sure I had them in the right order, but there was no mistaking what I saw. Or rather didn’t see. She had had a complete response, to which I can only attribute a secretive, nasty streak that she hides from all of us in clinic. I am on to you, Mrs. K. Your delicious Christmas cookies can’t fool me!

On a recent visit over a year later, feeling well and still without any sign of cancer, she told me she knew all along we would find something that would work. She had faith that things would come out OK, and gently chided me for continuing to hedge about the future. I am happy to admit I was wrong, that my superstition about her bad luck was completely ridiculous, and that I have learned a valuable lesson. And if I just happened to be wearing Starry Night on my tie again, I’m sure it was just a coincidence.

Nathan A. Pennell is an oncologist who blogs at ASCO Connection, where this post originally appeared.

Image credit: Shutterstock.com

Prev

The unsettling incongruity of a medical student's "lucky" day

October 30, 2015 Kevin 1
…
Next

An episode of low-value care delivered to my father

October 30, 2015 Kevin 25
…

Tagged as: Oncology and Hematology

< Previous Post
The unsettling incongruity of a medical student's "lucky" day
Next Post >
An episode of low-value care delivered to my father

 

ADVERTISEMENT

More by Nathan A. Pennell, MD, PhD

  • How social media changed this oncologist’s life

    Nathan A. Pennell, MD, PhD
  • An oncologist reflects on his inpatient internal medicine service

    Nathan A. Pennell, MD, PhD
  • This is why a computer algorithm cannot ever fully replace a doctor’s judgment

    Nathan A. Pennell, MD, PhD

Related Posts

  • A letter to a cancer patient in palliative care

    Alison Vasa
  • Happy National Grateful Patient Day!

    R. Lynn Barnett
  • My first patient to be diagnosed with cancer

    Ton La, Jr., MD, JD
  • A silent moment with a dying patient

    Anonymous
  • Including the patient perspective on tumor boards

    Don S. Dizon, MD
  • Losing my first patient

    Allie Poles

More in Conditions and Diseases

  • Shift work and circadian rhythms shape the 24/7 workplace

    Deepak Gupta, MD
  • Telehealth and postpartum psychosis defy simple blame

    Rabia Cheema, MD
  • Underage online gambling needs more than a checkbox

    Kayvan Haddadan, MD
  • Why must fourth trimester care begin after delivery?

    Allison P. Boyle, DPA, PA-C
  • Nutrition during cancer treatment is more than calories

    Dr. Manjari Chandra
  • Why witnessing death outside the hospital felt different

    Denise Moulton, RN
  • Most Popular

  • Past Week

    • Retirement isn’t the end of medicine, it’s a second act [PODCAST]

      The Podcast by KevinMD | Podcast
    • The conflict of interest that discloses as nothing

      Martha Rosenberg | Medications
    • Surgical judgment: the skill no one sees from the gallery

      Mustafa Kemal Çalık, MD | Physician
    • Why haven’t ambient AI scribes boosted productivity?

      Karan Kanwar | Health Technology
    • 3 reforms to counter wellness influencers in practice

      Farid Sabet-Sharghi, MD | Physician
    • Physician well-being is not an individual problem

      Heather Buckley | Conditions and Diseases
  • Past 6 Months

    • Why CDC opioid guidelines get the overdose data wrong

      Richard A. Lawhern, PhD | Conditions and Diseases
    • Retirement isn’t the end of medicine, it’s a second act [PODCAST]

      The Podcast by KevinMD | Podcast
    • Sensory processing in autism and the brain’s volume control

      Josette Pelatan, PhD | Conditions and Diseases
    • What maternity care deserts cost a town

      Manisha Kaliaperumal | Health Policy
    • Why medicine needs a national physician license now

      Vaishali Popat, MD, MPH | Physician
    • A cold cost $945. The cost of primary care is broken.

      Susan Newman, MD | Physician
  • Recent Posts

    • 3 reforms to counter wellness influencers in practice

      Farid Sabet-Sharghi, MD | Physician
    • Shift work and circadian rhythms shape the 24/7 workplace

      Deepak Gupta, MD | Conditions and Diseases
    • Paid for twice

      Physicians paid for G2211 twice. Most never bill it.

      Michael Duben, MD | Physician Finance
    • The next child

      Medicaid managed care and the case for mutual stewardship

      Steven Merahn, MD | Health Policy
    • Choosing a limb lengthening surgeon requires accountability

      Hrayr Basmajian, MD | Physician
    • Cited but never checked

      Why AI crisis advice may fail families facing psychosis

      Nicole Drapeau Gillen | Health Technology

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 4 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

  • Most Popular

  • Past Week

    • Retirement isn’t the end of medicine, it’s a second act [PODCAST]

      The Podcast by KevinMD | Podcast
    • The conflict of interest that discloses as nothing

      Martha Rosenberg | Medications
    • Surgical judgment: the skill no one sees from the gallery

      Mustafa Kemal Çalık, MD | Physician
    • Why haven’t ambient AI scribes boosted productivity?

      Karan Kanwar | Health Technology
    • 3 reforms to counter wellness influencers in practice

      Farid Sabet-Sharghi, MD | Physician
    • Physician well-being is not an individual problem

      Heather Buckley | Conditions and Diseases
  • Past 6 Months

    • Why CDC opioid guidelines get the overdose data wrong

      Richard A. Lawhern, PhD | Conditions and Diseases
    • Retirement isn’t the end of medicine, it’s a second act [PODCAST]

      The Podcast by KevinMD | Podcast
    • Sensory processing in autism and the brain’s volume control

      Josette Pelatan, PhD | Conditions and Diseases
    • What maternity care deserts cost a town

      Manisha Kaliaperumal | Health Policy
    • Why medicine needs a national physician license now

      Vaishali Popat, MD, MPH | Physician
    • A cold cost $945. The cost of primary care is broken.

      Susan Newman, MD | Physician
  • Recent Posts

    • 3 reforms to counter wellness influencers in practice

      Farid Sabet-Sharghi, MD | Physician
    • Shift work and circadian rhythms shape the 24/7 workplace

      Deepak Gupta, MD | Conditions and Diseases
    • Paid for twice

      Physicians paid for G2211 twice. Most never bill it.

      Michael Duben, MD | Physician Finance
    • The next child

      Medicaid managed care and the case for mutual stewardship

      Steven Merahn, MD | Health Policy
    • Choosing a limb lengthening surgeon requires accountability

      Hrayr Basmajian, MD | Physician
    • Cited but never checked

      Why AI crisis advice may fail families facing psychosis

      Nicole Drapeau Gillen | Health Technology

Copyright © 2026 KevinMD.com | Powered by Astra WordPress Theme

  • Terms of Use Agreement
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

A cancer patient who had bad luck with clinical trials
4 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...